Jianguo Zhi - Concepedia

Author

Jianguo Zhi

La Roche College ORCID

Also Known As

J G Zhi, J Q Zhi, J Zhi, J. G. Zhi, J. Zhi, Jessi Zhi, Jia Yin Zhi, Jianguo Zhi, Jianguo zhi, Jin-Xiu Zhi

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

La Roche College Roche (Switzerland)Princess Margaret Cancer Centre Jewish General Hospital Roche (United States)

About

Jianguo Zhi is an author at La Roche College specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1.3K
2	Health Sciences	5	5	265
3	Immunology	4	4	121
4	Biochemistry	1	1	20
5	Diabetes	1	1	37

Jianguo Zhi

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study Isabelle Ray‐Coquard, Jean‐Yves Blay, Antoîne Italiano, The Lancet Oncology Mdm2 Antagonist Rg7112MedicinePharmacologyPathologyAnti-cancer Agent	2012	553
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia Michael Andreeff, Kevin R. Kelly, Karen Yee, Clinical Cancer Research	2015	344
Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers Jianguo Zhi, Angela T. Melia, Roberto Guerciolini, Clinical Pharmacology & Therapeutics	1994	280
The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Absorption of Vitamins A and E in Healthy Volunteers Angela T. Melia, Susan G. Koss‐Twardy, Jianguo Zhi The Journal of Clinical Pharmacology	1996	115
A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma Geoffrey I. Shapiro, Patricia LoRusso, Afshin Dowlati, British Journal of Cancer	2020	115
Metabolic Profiles of Minimally Absorbed Orlistat in Obese/Overweight Volunteers Jianguo Zhi, Angela T. Melia, Christoph Funk, The Journal of Clinical Pharmacology	1996	94
Long‐Term Systemic Exposure of Orlistat, a Lipase Inhibitor, and Its Metabolites in Obese Patients Jianguo Zhi, Thomas E. Mulligan, Jonathan Hauptman The Journal of Clinical Pharmacology	1999	82
Phase 1/1b Study of RG7388, a Potent MDM2 Antagonist, in Acute Myelogenous Leukemia (AML) Patients (Pts) Karen Yee, Giovanni Martinelli, Norbert Vey, Blood	2014	82
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due toPseudomonas aeruginosa Jianguo Zhi, Charles H. Nightingale, Richard Quintiliani Journal of Pharmacokinetics and Biopharmaceutics Antimicrobial SusceptibilityHealth SciencesMedicinePathogenesisMicrobial Pharmacodynamics	1988	78
Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia Jing Li, Jianguo Zhi, Michael Wenger, The Journal of Clinical Pharmacology Hematological MalignancyLymphoid NeoplasiaOncologyHealth SciencesMedicine	2012	77

Page 1